Insulin aspart, recombinant Subcutaneous and Mometasone Furoate eent
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mometasone Furoate eent and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mometasone nasal
Brand name: Nasonex, Propel, Sinuva, Propel Mini, Propel Contour
Synonyms: Mometasone nasal, Mometasone (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Mometasone Furoate topical
- Insulin aspart, recombinant Subcutaneous-Mometasone Implantation
- Insulin aspart, recombinant Subcutaneous-Mometasone inhalation
- Insulin aspart, recombinant Subcutaneous-Mometasone Inhalation Aerosol
- Insulin aspart, recombinant Subcutaneous-Mometasone Inhalation Powder
- Insulin aspart, recombinant Subcutaneous-Mometasone Inhalation, oral/nebulization
- Mometasone Furoate eent-Insulin degludec
- Mometasone Furoate eent-Insulin Degludec (U-100) Prefilled Pens
- Mometasone Furoate eent-Insulin Degludec (U-100) Vials
- Mometasone Furoate eent-Insulin Degludec (U-200) Prefilled Pens
- Mometasone Furoate eent-Insulin degludec and liraglutide
- Mometasone Furoate eent-Insulin degludec and liraglutide Subcutaneous